Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

50%(3 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_2

25%

Ph phase_3

38%

Ph not_applicable

13%

Ph phase_4

13%

Ph phase_1

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

2(25.0%)

Phase 3Large-scale testing

3(37.5%)

Phase 4Post-market surveillance

1(12.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(1)

Other(1)

Detailed Status

Completed6

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (12.5%)

Phase 22 (25.0%)

Phase 33 (37.5%)

Phase 41 (12.5%)

N/A1 (12.5%)

Trials by Status

terminated113%

completed675%

unknown113%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_4

Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients

NCT04376762

completedphase_3

Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery

NCT01623531

completedphase_2

Clinical Trials (8)

Showing 8 of 8 trials

NCT04376762Phase 4

Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients

Completed

NCT01623531Phase 3

Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery

Completed

NCT02344069Phase 2

Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage

Completed

NCT00713596Not Applicable

Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty

Terminated

NCT00493272Phase 1

Dilutional Coagulopathy in Patients Undergoing Elective Surgery

Completed

NCT00968045Phase 2

Fibrinogen and Bleeding After Cardiac Surgery

Completed

NCT01471730Phase 3

The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery

Completed

NCT01539057Phase 3

The Efficacy of the Administration of Fibrinogen in Liver Transplantation

Unknown

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8